CD8A and relapsing-remitting multiple sclerosis: In addition, CD94/NKG2A killer suppressor receptors inhibit CD8+ regulatory T cell cloning and killing of other immune cells, exacerbating the disease in RRMS patients (Correale and Villa, 2008; Uemura et al., 2008).